Stay updated on Capivasertib+Fulvestrant vs Placebo+Fulvestrant Clinical Trial
Sign up to get notified when there's something new on the Capivasertib+Fulvestrant vs Placebo+Fulvestrant Clinical Trial page.

Latest updates to the Capivasertib+Fulvestrant vs Placebo+Fulvestrant Clinical Trial page
- Check4 days agoChange DetectedThe ClinicalTrials.gov record for the CAPItello-291 breast cancer study is available with its study details, results-related information, participating locations, and supporting documents.SummaryDifference100%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2, while the page continues to show a 403 access error.SummaryDifference0.2%

- Check25 days agoChange DetectedA site-wide NIH notice appears above the ClinicalTrials.gov page, announcing updates to NIH terminology and linking to transition information.SummaryDifference1%

- Check32 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check39 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check53 days agoChange Detected403 Forbidden error is shown on the study page, replacing the normal study record content and navigation. Users cannot access the CAPItello-291 trial details as a result.SummaryDifference16%

Stay in the know with updates to Capivasertib+Fulvestrant vs Placebo+Fulvestrant Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Capivasertib+Fulvestrant vs Placebo+Fulvestrant Clinical Trial page.